valrubicin

DRUG4 trials

Sponsors

Eastern Cooperative Oncology Group, Anthra Pharmaceuticals, H. Lee Moffitt Cancer Center and Research Institute

Conditions

Bladder CancerUrothelial Carcinoma

Phase 1

Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma

CompletedNCT01606345

H. Lee Moffitt Cancer Center and Research InstituteUrothelial Carcinoma

Start: 2012-07-31End: 2016-04-30Updated: 2016-04-22

Phase 2

Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

CompletedNCT00003129

Eastern Cooperative Oncology GroupBladder Cancer

Start: 1998-09-01End: 2009-05-01Target: 75Updated: 2023-06-22

AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer

CompletedNCT00003759

Anthra PharmaceuticalsBladder Cancer

Start: 1998-11-30End: 2002-11-30Updated: 2013-01-31

Phase 3

Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Anthra PharmaceuticalsBladder Cancer

Start: 1996-12-31Target: 300Updated: 2013-11-06